A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd). The ...

AstraZeneca and Daiichi Sankyo have moved swiftly to file for FDA approval of a second indication for their TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd), this time for ...

McDonald's Grinch meal vs. Burger King's SpongeBob menu: Here's the obvious winner Drone video captures flooded Puyallup River as Washington issues warning House passes $901B military defense bill ...

Meta is encouraging users to verify themselves to unlock more features or engagement with their posts. Endangered species are being sold online with UK-based firms illegally supplying seahorses, a BBC ...

Download ProShares UltraShort Dow30 stock data: historical DXD stock prices from MarketWatch.

Department of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331-3507, and Laboratory of Microbial Metabolism and School of Life Science & Biotechnology, Shanghai Jiaotong ...

Patient Deaths Put Merck, Daiichi Sankyo’s Antibody-Drug Conjugate on Hold The fatalities were attributed to interstitial lung disease, a known side effect of Daiichi Sankyo’s DXd-based antibody-drug ...

Tristan is an independent science writer based in Metro Manila, with more than eight years of experience writing about medicine, biotech and science. He can be reached at [email protected], ...